Press Release Medical Technology/Oncology 1 min read

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

Australian medical technology company Ferronova has raised an additional $6 million in a Series A extension round led by existing investors to advance clinical trials and commercialization of its nanoparticle image-guided surgery technology for stomach and oesophageal cancers.

Uniseed/UniSuper South Australian Venture Capital Fund Artesian Venture Partners Renew Pharmaceuticals Ferronova UltraGreen.ai University of South Australia Powerhouse Ventures University of Wellington University of Sydney PAN Ventures STOIC Venture Capital Perennial Partners Future of HealthCare Fund
Press ReleaseDecember 17, 2025
Uniseed/UniSuper

Australian medical technology company Ferronova has raised an additional $6 million in a Series A extension round led by existing investors to advance clinical trials and commercialization of its nanoparticle image-guided surgery technology for stomach and oesophageal cancers.

Related articles

Press ReleaseMay 8, 2026
West Enclave Merger Corp.

West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026

May 8, 2026
Press ReleaseMay 8, 2026
Shreya Acquisition Group

Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)

May 8, 2026
Press ReleaseMay 8, 2026
Consolidated Edison

Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program

May 8, 2026
← Back to all articles

Generated by Yeal